NFYB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.287400E-01
Normal-vs-Stage2
6.955600E-01
Normal-vs-Stage3
4.184400E-01
Normal-vs-Stage4
8.175400E-01
Stage1-vs-Stage2
7.897000E-01
Stage1-vs-Stage3
5.121800E-01
Stage1-vs-Stage4
6.434000E-01
Stage2-vs-Stage3
6.370200E-01
Stage2-vs-Stage4
4.121000E-01
Stage3-vs-Stage4
4.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.769200E-01
Normal-vs-AfricanAmerican
6.135800E-01
Normal-vs-Asian
1.204160E-01
Caucasian-vs-AfricanAmerican
8.636000E-01
Caucasian-vs-Asian
4.465900E-02
AfricanAmerican-vs-Asian
1.534830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.292600E-01
Normal-vs-Female
5.688800E-01
Male-vs-Female
3.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.177200E-01
Normal-vs-Age(41-60Yrs)
9.103400E-01
Normal-vs-Age(61-80Yrs)
5.481800E-01
Normal-vs-Age(81-100Yrs)
2.888800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.745800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.571200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.206600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.976300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.325700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.350400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.135000E-01
Normal-vs-Daily Drinker
2.525600E-01
Normal-vs-Weekly Drinker
5.413600E-01
Normal-vs-Occasional Drinker
3.302600E-01
Normal-vs-Social Drinker
8.895000E-01
Non Drinker-vs-Daily Drinker
5.384600E-01
Non Drinker-vs-Weekly Drinker
9.046000E-01
Non Drinker-vs-Occasional Drinker
7.345000E-01
Non Drinker-vs-Social Drinker
3.423400E-01
Daily Drinker-vs-Weekly Drinker
6.202800E-01
Daily Drinker-vs-Occasional Drinker
7.076400E-01
Daily Drinker-vs-Social Drinker
8.553700E-02
Weekly Drinker-vs-Occasional Drinker
8.503400E-01
Weekly Drinker-vs-Social Drinker
2.515400E-01
Occasional Drinker-vs-Social Drinker
1.405620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.188200E-01
Normal-vs-Grade 2
1.713220E-01
Normal-vs-Grade 3
6.481800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.151600E-01
Grade 1-vs-Grade 3
8.837200E-01
Grade 1-vs-Grade 4
2.188200E-01
Grade 2-vs-Grade 3
3.317800E-01
Grade 2-vs-Grade 4
1.713220E-01
Grade 3-vs-Grade 4
6.481800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.857400E-01
Normal-vs-NonDiabetic
6.459800E-01
Diabetic-vs-NonDiabetic
6.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.888000E-01
Normal-vs-NoPancreatitis
6.160000E-01
Pancreatitis-vs-NoPancreatitis
8.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.730800E-01
Normal-vs-N1
7.640600E-01
N0-vs-N1
7.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.474400E-01
Normal-vs-TP53-NonMutant
9.924400E-01
TP53-Mutant-vs-TP53-NonMutant
2.315600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
